RNA Modifiers

L L • November 25, 2017
Advanced RNA Modifier Reagents: See the Full List

RNA Modifiers

See the full list of in-house RNA Modifiers used in our synthesis

Optimized Nucleotide Synthesis

While most modifications to RNA are built for maintenance, demand in new and improved compounds is growing for various use of synthetic RNA. A major one is gRNA for recent CRISPR/CAS9 systems, but the more veteran application for RNA modifiers is undoubtedly antisense RNA. In order to harness the mechanistic advantages of RNA interference, custom nucleotide sequences need to be equipped with the ability to permeate cell walls, bind to the target and protect itself from degradation. We offer an advanced selection of 2’-O-alkyl/methyl compounds along with affinity and fluorescent labels to follow a sequence in experiments all throughout its development.

RNA Synthesis/Modifiers & Labelling

Modifiers
N 3 -Methyl-uridine-DMTr-3'-Icaa CPG
N 3 -Thiobenzoylethyl-uridine-DMTr-3'-Icaa CPG
N 4 -Ethyl-cytidine-DMTr-3'-Icaa CPG
N 6 -Benzyl-adenosine-DMTr-3'-Icaa CPG
N 6 -Isopentenyl-adenosine-DMTr-3'-Icaa CPG
Pseudo-uridine-DMTr-3'-Icaa CPG
Purine-riboside-DMTr-3'-Icaa CPG
Thymidine-DMTr-3'-Icaa CPG
Uridine-DMTr-3'-Icaa CPG
β -L- Thymidine-DMTr-3'-Icaa CPG
β -L-Adenosine ( N -Bz)-DMTr 3'-Icaa CPG
β -L-Cytidine ( N -Ac)-DMTr 3'-Icaa CPG
β -L-Cytidine ( N -Bz)-DMTr 3'-Icaa CPG
β -L-Guanosine ( N -iBu)-DMTr 3'-Icaa CPG
β -L-Uridine-DMTr 3'-Icaa CPG
(2)-Amino (TFA) Protected RNA 3'-CPG
2-Amino-2'-amino (TFA)-uridine-DMTr-3'-Icaa CPG
2'-Amino (TFA)-cytidine ( N -Bz) CPG
Puromycin Supports
3'-L- O -Methyl-tyrosine-puromycin-2'- Icaa CPG
Puromycin 2'-succinyl Icaa CPG
RNA Synthesis: Purification Kit
Anhydrous Ammonia in Ethanol Solution (20% ammonia by wt in absolute ethanol)
Fluoride Ion Removal Solution
Tetra butyl Ammonium Fluoride (1 M Sol in THF)
Levulinyl Deprotection Solution
Levulinyl Deprotection Solution
O-Alkyl & Antisenses Oligonucleotide Modifications

2'- O -Methyl-RNA Synthesis

A: CE Phosphoramidites (RNA synthesis)
(1)-2'-O-Me RNA Phosphoramidites
2'- O -Methyl-adenosine ( N -Bz)-DMTr-3'-CEP
2'- O -Methyl-adenosine ( N -Bz)-MMTr-3'-CEP
2'- O -Methyl-cytidine ( N -Ac)-DMTr-3'-CEP
2'- O -Methyl-cytidine ( N -Bz)-DMTr-3'-CEP
2'- O -Methyl-guanosine ( N -iBu)-DMTr-3'-CEP
2'- O -Methyl-guanosine ( N -iBu)-MMTr-3'-CEP
2'- O -Methyl-uridine-DMTr-3'-CEP
(2)-2'-O-Me RNA Phosphoramidites (mild protection)
2'- O -Methyl-adenosine ( N -PAC)-DMTr-3'-CEP
2'- O -Methyl-cytidine ( N -Ac)-DMTr-3'-CEP
2'- O -Methyl-cytidine ( N -PAC)-DMTr-3'-CEP
2'- O -Methyl-guanosine ( N -DMF)-DMTr-3'-CEP
2'- O -Methyl-guanosine ( N -iPrPAC)-DMTr-3'-CEP
2'- O -Methyl-guanosine ( N -PAC)-DMTr-3'-CEP
2'- O -Methyl-uridine-DMTr-3'-CEP
B: Minor 2'-O-Me-RNA Phosphoramidites
2'- O -Methyl-5-propynyl-uridine-DMTr-3'-CEP
2'- O -Methyl-uridine (C-6)-DMTr-3'-CEP (Amino Modifier)\"
2'- O -Methyl-2,6-diamino-purine ( N 2, N 6-diPAC)-DMTr-3'-CEP
2'- O -Methyl-4-triazolyl-uridine-DMTr-3'-CEP
2'- O -Methyl-5-bromo-uridine-DMTr-3'-CEP
2'- O -Methyl-5-iodo-uridine-DMTr-3'-CEP
2'- O -Methyl-5-methyl-cytidine ( N -Ac)-DMTr-3'-CEP
2'- O -Methyl-5-methyl-cytidine ( N -Bz)-DMTr-3'-CEP
2'-O-Methyl-5-methyl-cytidine ( N -DMF)-DMTr-3'-CEP
2'- O -Methyl-5-methyl-uridine (Ribo Thymidine)-DMTr-3'-CEP
2'- O -Methyl-5-propynyl-cytidine ( N -Bz)-DMTr-3'-CE
2'- O -Methyl-7-deaza 7-iodo-adenosine ( N -Bz)-DMTr-3'-CEP
2'- O -Methyl-7-deaza 7-Iodo-guanosine ( N -iBu)-DMTr-3'-CEP
2'- O -Methyl-7-deaza-7-propargyl (Amino- TFA)-guanosine ( N -iBu)-DMTr-3'-CEP
2'- O -Methyl-7-deaza-7-propargyl(Amino-TFA)-adenosine ( N -Bz)-DMTr-3'-CEP
2'- O -Methyl-7-deaza-adenosine ( N -Bz)-DMTr-3'-CEP
2'- O -Methyl-7-deaza-guanosine ( N -iBu)-DMTr-3'-CEP
2'- O -Methyl-cytidine ( N -DMF)-DMTr-3'-CEP (Amino Modifier)
2'- O -Methyl-Inosine-DMTr-3'-CEP
C-Backbone 2'-O-Me-RNA modificatios
(1)- P-O -Ethyl Phosphoramidites
2'- O -Methyl- P-O -ethyl-adenosine ( N -Bz)-DMTr-3'-CEP
2'- O -Methyl- P-O -ethyl-adenosine ( N -PAC)-DMTr-3'-CEP
2'- O -Methyl- P-O -ethyl-cytidine ( N -Bz)-DMTr-3'-CEP
2'- O -Methyl- P-O -ethyl-cytidine ( N -PAC)-DMTr-3'-CEP
2'- O -Methyl- P-O -ethyl-guanosine ( N -iBu)-DMTr-3'-CEP
2'- O -Methyl- P-O -ethyl-guanosine ( N -PAC)-DMTr-3'-CEP
2'- O -Methyl- P-O- ethyl-thymidine-DMTr-3'-CEP
2'- O -Methyl- P-O- ethyl-uridine-DMTr-3'-CEP
(2)-Methyl RNA Phosphoramidites
2'- O -Methyl- P -methyl-adenosine ( N -Bz)-DMTr-3'-CEP
2'- O -Methyl- P -methyl-cytidine ( N -Ac)-DMTr-3'-CEP
2'- O -Methyl- P -methyl-cytidine ( N -iBu)-DMTr-3'-CEP
2'- O -Methyl- P -methyl-guanosine ( N -iBu)-DMTr-3'-CEP
2'- O -Methyl- P -methyl-uridine-DMTr-3'-CEP
D: Supports For 2'-OME RNA Synthesis
(1)-2'-OMe-RNA 3'-CPG
2'- O -Methyl-adenosine ( N -Bz)-DMTr-3'-Icaa CPG
2'- O -Methyl-cytidine ( N -Ac)-DMTr-3'-Icaa CPG
2'- O -Methyl-cytidine ( N -Bz)-DMTr-3'-Icaa CPG
2'- O -Methyl-guanosine ( N -DMF)-MMTr-3'-Icaa CPG
2'- O -Methyl-guanosine ( N -iBu)-DMTr-3'-Icaa CPG
2'- O -Methyl-uridine-DMTr-3'-Icaa CPG
(2)-2'-OMe-RNA 3'-CPG (mild protection)
2'- O -Methyl-adenosine ( N -PAC)-DMTr-3'-Icaa CPG
2'- O -Methyl-cytidine ( N -Ac)-DMTr-3'-Icaa CPG
2'- O -Methyl-cytidine ( N -PAC)-DMTr-3'-Icaa CPG
2'- O -Methyl-guanosine ( N -PAC)-DMTr-3'-Icaa CPG
(3)-Minor 2'-OMe-RNA 3'-CPG
2'- O -Methyl-5-methyl-cytidine ( N -DMF)-DMTr-3'-Icaa CPG
2'- O -Methyl-5-bromo-uridine-DMTr-3'-Icaa CPG
2'- O -Methyl-5-iodo-uridine-DMTr-3'-Icaa CPG
2'- O -Methyl-5-methyl-cytidine ( N -Bz)-DMTr-3'-Icaa CPG
2'- O -Methyl-inosine-DMTr-3'-Icaa CPG
2'- O -Methyl-thymidine-DMTr-3'-Icaa CPG

2'-O-Me 5'→ 3' RNA Synthesis

A: 2'-O-Me 5'-CE RNA Phosphoramidites
2'- O -Methyl-adenosine ( N -Bz)-DMTr-5'-CEP
2'- O -Methyl 5-methyl-uridine-DMTr-5'-CEP
2'- O -Methyl-5-methyl-cytidine ( N -Bz)-DMTr-5'-CEP
2'- O -Methyl-cytidine ( N -Ac)-DMTr-5'-CEP
2'- O -Methyl-cytidine ( N -Bz)-DMTr-5'-CEP
2'- O -Methyl-guanosine ( N -iBu)-DMTr-5'-CEP
2'- O -Methyl-uridine-DMTr-5'-CEP
B: Support:2'-O-Me 5'-CPG
2'- O -Methyl-5-methyl-cytidine ( N -Bz)-DMTr-5'-Icaa CPG
2'- O -Methyl-5-methyl-uridine-DMTr-5'-Icaa CPG
2'- O -Methyl-adenosine ( N -Bz)-DMTr-5'-Icaa CPG
2'- O -Methyl-cytidine ( N -Ac)-DMTr-5'-Icaa CPG
2'- O -Methyl-cytidine ( N -Bz)-DMTr-5'-Icaa CPG
2'- O -Methyl-guanosine ( N -iBu)-DMTr-5'-Icaa CPG
2'- O -Methyl-uridine-DMTr-5'-Icaa CPG

2'-F RNA Synthesis

A: CE Phosphoramidites
(1)-2'-F-RNA Monomers
2'-Fluoro-2'-deoxyadenosine ( N -DMF)-DMTr-3'-CEP
2'-Fluoro-2'-deoxyadenosine ( N -Bz)-DMTr-3'-CEP
2'-Fluoro-2'-deoxycytidine ( N -Ac)-DMTr-3'-CEP
2'-Fluoro-2'-deoxyguanosine ( N -DMF)-DMTr-3'-CEP
2'-Fluoro-2'-deoxyguanosine ( N -iBu)-DMTr-3'-CEP
2'-Fluoro-2'-deoxyuridine-DMTr-3'-CEP
(2)-2'-F-RNA Monomers (Ultramild)
2'-Fluoro-2'-deoxyadenosine ( N -PAC)-DMTr-3'-CEP
2'-Fluoro-2'-deoxycytidine ( N -Ac)-DMTr-5'-CEP
2'-Fluoro-2'-deoxyguanosine ( N -iPrPAC)-DMTr-3'-CEP
2'-Fluoro-2'-deoxyuridine-DMTr-5'-CEP
B: Minor 2'-F-RNA Monomers
2'-Fluoro-2'-deoxyinosine-DMTr-3'-CEP
2'-Fluoro-5-iodo-2'-deoxyuridine-DMTr-3'-CEP
2'-Fluoro-5-methyl-2'-deoxycytidine ( N -Ac)-DMTr-3'-CEP
2'-Fluoro-5-methyl-2'-deoxycytidine ( N -Bz)-DMTr-3'-CEP
2'-Fluoro-5-methyl-2'-deoxyuridine-DMTr-3'-CEP
C: Supports
(1)-Support-3'-CPG
2'-Fluoro-2'-deoxyadenosine ( N -DMF)-DMTr-3'-Icaa CPG
2'-Fluoro-2'-deoxyadenosine ( N -Bz)-DMTr-3'-Icaa CPG
2'-Fluoro-2'-deoxycytidine ( N -Ac)-DMTr-3'-Icaa CPG
2'-Fluoro-2'-deoxyguanosine ( N -DMF)-DMTr-3'-Icaa CPG
2'-Fluoro-2'-deoxyguanosine ( N -iBu)-DMTr-3'-Icaa CPG
2'-Fluoro-2'-deoxyuridine-DMTr-3'-Icaa CPG

2'- O -Butyne RNA Synthesis

A: 2'-O-Butyne-RNA Phosphonamidites
2'- O -Butyne-aenosine ( N -Bz)-DMTr 3'-CEP
2'- O -Butyne-cytidine ( N -Bz)-DMTr-3'-CEP
2'- O -Butyne-guanosine ( N -iBu)-DMTr-3'-CEP
2'- O -Butyne-uridine-DMTr-3'-CEP
B: Supports: 2'-O-Butyne-RNA 3'-CPG
2'- O -Butyne-adenosine ( N -Bz)-DMTr-3'-Icaa CPG
2'- O -Butyne-cytidine ( N -Bz)-DMTr-3'-Icaa CPG
2'- O -Butyne-guanosine ( N -iBu)-DMTr-3'-Icaa CPG
2'- O -Butyne-uridine-DMTr-3'-Icaa CPG

RNA: 2'- O -Propargyl RNA Synthesis (Combiclick TM Chemistry)

A: 2'- O -Propargyl RNA Phosphoramidites
2'- O -Propargyl-adenosine ( N -Bz)-DMTr-3'-CEP
2'- O -Propargyl-cytidine ( N -Ac)-DMTr-3'-CEP
2'- O -Propargyl-cytidine ( N -Bz)-DMTr-3'-CEP
2'- O -Propargyl-guanosine ( N -iBu)-DMTr-3'-CEP
2'- O -Propargyl-inosine-DMTr-3'-CEP
2'- O -Propargyl-uridine-DMTr-3'-CEP
B: 2'-O-Propargyl RNA:Minor Phosphoramidites
2'- O -Propargyl-abasic-DMTr-3’-CEP; 2'- O -Propargyl-1,1 dihydro-β-D-ribose-DMTr-3’-CEP
2'- O -Propargyl-abasic-DMTr-3’-Icaa CPG
Ara-Propargyl-inosine-DMTr-3’-CEP
C: Supports-2'-O-Propargyl RNA 3'-CPG
2'- O -Propargyl-adenosine ( N -Bz) DMTr 3'-Icaa CPG
2'- O -Propargyl-cytidine ( N -Ac) DMTr 3'-Icaa CPG
2'- O -Propargyl-cytidine ( N -Bz) DMTr 3'-Icaa CPG
2'- O -Propargyl-guanosine ( N -iBu) DMTr 3'-Icaa CPG
2'- O -Propargyl-inosine DMTr 3'-Icaa CPG
2'- O -Propargyl-uridine DMTr 3'-Icaa CPG

RNA: 2'-O-Hexyne RNA Synthesis

A: 2'-O-Hexyne RNA Phosphoramidites
2'- O -Hexyne-inosine-DMTr-3’-CEP
2'- O -Hexyne-1,1 dihydro-β-D-ribose-DMTr-3’-CEP

RNA: 3'-O-Alkyl RNA Synthesis

A: 3'- O -Alkyl RNA phosphoramidites
(1)-3'- O -Methyl-RNA Phosphoramidites
3'- O -Methyl-adenosine ( N -Bz)-DMTr-2'-CEP
3'- O -Methyl-cytidine ( N -Ac)-DMTr-2'-CEP
3'- O -Methyl-cytidine ( N -Bz)-DMTr-2'-CEP
3'- O -Methyl-guanosine ( N -iBu)-DMTr-2'-CEP
3'- O -Methyl-inosine-DMTr-2'-CEP
3'- O -Methyl-thymidine-DMTr-2'-CEP
3'- O -Methyl-uridine-DMTr-2'-CEP
(2)-3'-O-Propargyl RNA Phosphoramidites
3'- O -Propargy-cytidine ( N -Ac)-DMTr-2'-CEP
3'- O -Propargyl-adenosine ( N -Bz)-DMTr-2'-CEP
3'- O -Propargyl-cytidine ( N -Bz)-DMTr-2'-CEP
3'- O -Propargyl-guanosine ( N -iBu)-DMTr-2'-CEP
3'- O -Propargyl-uridine-DMTr-2'-CEP
B: 3'-O-Alkyl RNA Supports
(1)-Supports:3'- O -ME-RNA 2'-CPG
3'- O -Methyl-adenosine ( N -Bz)-DMTr-2'-Icaa CPG
3'- O -Methyl-cytidine ( N -Bz)-DMTr-2'-Icaa CPG
3'- O -Methyl-guanosine ( N -iBu)-DMTr-2'-Icaa CPG
3'- O -Methyl-inosine-DMTr-2'-Icaa CPG
3'- O -Methyl-uridine-DMTr-2'-Icaa CPG
(2)-Supports:3'-O-Propargyl RNA 2'-CPG
3'- O -Propargyl-adenosine ( N -Bz)-DMTr-2'-Icaa CPG
3'- O -Propargyl-cytidine ( N -Ac)-DMTr-2'-Icaa CPG
3'- O -Propargyl-cytidine ( N -Bz)-DMTr-2'-Icaa CPG
3'- O -Propargyl-guanosine ( N -iBu)-DMTr-2'-Icaa CPG
3'- O -Propargyl-uridine-DMTr-2'-Icaa CPG

JPM 52:25

By Ed Hamdeh • January 7, 2025
Explore key insights and major trends from a decade of JPM Biotech conferences. Download our exclusive 2025 prospectus for the latest in biotech deals and innovations.
The Advantages and Applications of Recombinant technology | kbDNA

Advantages and Applications of Recombinant Antibodies

By Laith Khalil • October 25, 2024
Explore the advantages of recombinant antibodies. Discover their applications in research, diagnostics & therapeutics. Transform your R&D with precision.
kbDNA | Specialty Synthesis & Recombinant Technology

FLAG Tag: A Comprehensive Overview for Biopharmaceutical Research

By kBDNA Team • October 25, 2024
The FLAG tag (DYKDDDDK) is an epitope tag widely utilized in biopharmaceutical research for protein purification, detection, and functional analysis. This article provides an in-depth examination of FLAG tag technology, its advantages, limitations, and diverse applications. Additionally, it explores current research trends and future directions in FLAG tag technology, making it a pivotal tool in advancing drug discovery and development.